Halozyme Therapeutics
HALO
#2120
Rank
$7.50 B
Marketcap
$59.24
Share price
-0.44%
Change (1 day)
49.60%
Change (1 year)

Halozyme Therapeutics (HALO) - Total assets

Total assets on the balance sheet as of June 2024 : $1.96 B

According to Halozyme Therapeutics's latest financial reports the company's total assets are $1.96 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Halozyme Therapeutics - Total assets on balance sheet (from 2002 to 2024)

Total assets by year

Year Total assets Change
2023-12-31$1.73 B-5.88%
2022-12-31$1.84 B66.74%
2021-12-31$1.10 B90.44%
2020-12-31$0.57 B2.48%
2019-12-31$0.56 B28.54%
2018-12-31$0.44 B-15.33%
2017-12-31$0.51 B98.82%
2016-12-31$0.26 B43.86%
2015-12-31$0.18 B9.53%
2014-12-31$0.16 B63.05%
2013-12-31$0.10 B-24.45%
2012-12-31$0.13 B104.88%
2011-12-31$65.75 M-28.01%
2010-12-31$91.34 M18.4%
2009-12-31$77.14 M0.77%
2008-12-31$76.56 M-26%
2007-12-31$0.10 B124.47%
2006-12-31$46.09 M124.72%
2005-12-31$20.51 M25.03%
2004-12-31$16.4 M2434.38%
2003-12-31$0.64 M180.7%
2002-12-31$0.23 M782.54%
2001-12-31$0.02 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
$0.44 B-77.46%๐Ÿ‡บ๐Ÿ‡ธ USA
$71.87 B 3,549.49%๐Ÿ‡บ๐Ÿ‡ธ USA
$26.31 B 1,236.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$216.19 B 10,877.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$139.09 B 6,962.63%๐Ÿ‡ซ๐Ÿ‡ท France
$181.08 B 9,094.85%๐Ÿ‡บ๐Ÿ‡ธ USA